Zhuravleva Irina Yu
E. Meshalkin National Medical Research Center, Ministry of Health of Russian Federation, 15 Rechkunovskaya St., Novosibirsk 630055, Russia.
J Funct Biomater. 2025 Jul 7;16(7):250. doi: 10.3390/jfb16070250.
The development of transcatheter mitral valves (TMVs) represents a major advancement in cardiology, driven in part by the growing elderly population. Elderly patients frequently suffer from secondary mitral regurgitation but are often ineligible for surgical valve replacement due to high procedural risks. This study aimed to develop a self-expanding TMV stent fabricated from a single nitinol tube, featuring two distinct central zones: a smaller-diameter valve-containing segment and a larger-diameter anchoring segment for the mitral annulus. We used the COMSOL Multiphysics 6.0 software package for biotechnical engineering. Prototypes of stents and valves were manufactured in five sizes following a 22 Fr delivery system compatibility assessment and pulsatile-flow testing. We bioengineered a novel stent design with an integrated porcine pericardial valve. The stents were laser-cut from nitinol tubes (4.5 mm outer diameter, 0.45 mm wall thickness) and heat-treated to achieve spatial configurations compatible with fibrous ring diameters of 40, 42, 44, 46, and 48 mm. Pericardial leaflets and coverings were then mounted onto the stents. The resulting valves were successfully loaded into a 24 Fr delivery system and exhibited proper opening and closing function under pulsatile-flow testing. Our findings confirm the feasibility of a single-component, dual-diameter TMV stent, offering a promising solution for high-risk patients with mitral regurgitation.
经导管二尖瓣(TMV)的发展是心脏病学领域的一项重大进展,部分原因是老年人口的不断增加。老年患者经常患有继发性二尖瓣反流,但由于手术风险高,往往不符合手术瓣膜置换的条件。本研究旨在开发一种由单个镍钛诺管制成的自膨胀TMV支架,其具有两个不同的中心区域:一个直径较小的含瓣膜段和一个直径较大的用于二尖瓣环的锚定段。我们使用COMSOL Multiphysics 6.0软件包进行生物工程。在进行22 Fr输送系统兼容性评估和脉动流测试后,制造了五种尺寸的支架和瓣膜原型。我们生物工程设计了一种带有集成猪心包瓣膜的新型支架。支架由镍钛诺管(外径4.5 mm,壁厚0.45 mm)激光切割而成,并经过热处理以实现与40、42、44、46和48 mm纤维环直径兼容的空间构型。然后将心包小叶和覆盖物安装到支架上。所得瓣膜成功装入24 Fr输送系统,并在脉动流测试中表现出正常的开闭功能。我们的研究结果证实了单组件、双直径TMV支架的可行性,为二尖瓣反流的高危患者提供了一个有前景的解决方案。